A Photodynamic Therapy for Treatment of Actinic Keratoses
Not Applicable
Completed
- Conditions
- Actinic Keratoses
- Interventions
- Procedure: Photodynamic therapy
- Registration Number
- NCT00558688
- Lead Sponsor
- Northwestern University
- Brief Summary
The purpose of this study is to compare the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs absence of treatment for actinic keratoses.
- Detailed Description
This study seeks to evaluate the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs. absence of treatment for actinic keratoses
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Age greater than or equal to 18 years
- Have a t least 4 nonhypertrophic AK lesions on the body
- The subjects are in good health
- The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate to the investigator
Exclusion Criteria
- Subjects who are pregnant or lactating
- Subjects with a history of cutaneous photosensitivity or porphyria, hypersensitivity to porphyrins, or photodermatosis
- Subjects with use of photosensitizing drugs within 1 week of study start
- Subjects with use of topical medications such as corticosteroids, alpha-hydroxyacids or retinoids 2 weeks before study entry
- Subjects with systemic steroid therapy within 4 weeks before study entry
- Subjects who received previous treatment of target AKs
- Subjects with systemic treatment with chemotherapeutic agents, masoprocol (Actinex), immunotherapy, or retinoids within 2 months of study entry
- Subjects with prior history of hypersensitivity reactions to lidocaine
- Subjects who are unable to understand the protocol or to give informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Photodynamic therapy Light Therapy 2 Photodynamic therapy Light Therapy
- Primary Outcome Measures
Name Time Method Visual assessment of lesions 4 weeks
- Secondary Outcome Measures
Name Time Method Patient subjective assessment and Safety 4 weeks
Trial Locations
- Locations (1)
Northwestern University Department of Dermatology
🇺🇸Chicago, Illinois, United States